Overview

Ketamine and Propofol NeuroImaging

Status:
RECRUITING
Trial end date:
2028-08-02
Target enrollment:
Participant gender:
Summary
This is a multi-visit which will collect MRI (pictures of the brain) and EEG (brain waves) data to determine changes in brain connectivity and brain activity for memory formation and pain perception while receiving the commonly-used anesthetic agents ketamine and propofol, both alone and in combination.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Keith M Vogt
Collaborator:
National Institute of General Medical Sciences (NIGMS)
Treatments:
Ketamine
Propofol
Transcutaneous Electric Nerve Stimulation